Oral cancer detection and progression prediction using noninvasive cytology‐based DNA ploidy approach
Journal of Oral Pathology & Medicine · 2024-08 · 53 (7) · 434-443
DOI: 10.1111/jop.13562 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oral Pathology & Medicine, online erschienen am 02.06.2024. Verfasst von Kelly Y P Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medical Biological Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Disease Progression, Mouth Neoplasms, Ploidies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Mitacs Accelerate, Canadian Cancer Society Research Institute, Michael Smith Health Research BC.
Abstract (Originalsprache)
Background
Despite the oral cavity being readily accessible, oral cancer (OC) remains a significant burden. The objective of this study is to develop a DNA ploidy‐based cytology test for early detection of high‐risk oral lesions.
Methods
This retrospective study was conducted using 569 oral brushing samples collected from 95 normal and 474 clinically abnormal mucosa with biopsy diagnosis of reactive, low‐grade or high‐grade precancer or cancers. Brushing cells were processed to characterize DNA ploidy. A two‐step DNA ploidy‐based algorithm, the DNA ploidy oral cytology (DOC) test, was developed using a training set, and verified in test and validation sets to differentiate high‐grade lesions (HGLs) from normal. The prognostic value of the test was evaluated by an independent outcome cohort, including progressed and non‐progressing normal, reactive and low‐grade lesions. Classification performance was assessed by accuracy, sensitivity, and specificity, while the prognostic value was evaluated by using the Cox proportional hazards analysis on 3‐year progression‐free survival (PFS).
Results
The developed DOC test exhibited high accuracy for detecting HGLs in the test and validation sets, with a sensitivity of 0.97 and 0.96, respectively. Its application to the Outcome cohort demonstrated significant prognostic value for 3‐year PFS (log rank, p < 0.001). Multivariate analysis showed that high‐grade pathology was the only variable explaining positive DOC test, not age, smoking, or lesional site.
Conclusion
Clinical implementation of the DOC test could provide an effective screening method for detecting HGLs for biopsy and lesions at risk of progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral Medical Biological Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Integrative Oncology, BC Cancer, Vancouver, British Columbia, Canada.
- School of Biomedical Engineering, Faculty of Applied Science, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Förderung
- Mitacs Accelerate
- Canadian Cancer Society Research Institute
- Michael Smith Health Research BC
Zitieren
APA
Liu, K. Y. P., Ng, S., Taleghani, M., Zhu, S. Y., Carraro, A., Chen, Z., Palcic, B., Poh, C. F., & Guillaud, M. (2024). Oral cancer detection and progression prediction using noninvasive cytology‐based DNA ploidy approach. Journal of Oral Pathology & Medicine, 53(7), 434-443. https://doi.org/10.1111/jop.13562
Vancouver
Liu KYP, Ng S, Taleghani M, Zhu SY, Carraro A, Chen Z, et al. Oral cancer detection and progression prediction using noninvasive cytology‐based DNA ploidy approach. Journal of Oral Pathology & Medicine. 2024;53(7):434-443. doi:10.1111/jop.13562
BibTeX
@article{Liu2024,
author = {Liu, Kelly Y P and Ng, Samson and Taleghani, Maryam and Zhu, Sarah Y and Carraro, Anita and Chen, Zhaoyang and Palcic, Branko and Poh, Catherine F and Guillaud, Martial},
title = {Oral cancer detection and progression prediction using noninvasive cytology‐based DNA ploidy approach},
journal = {Journal of Oral Pathology & Medicine},
year = {2024},
volume = {53},
number = {7},
pages = {434--443},
doi = {10.1111/jop.13562}
}
EUVIMED